Odours are first captured by special olfactory nerve cells inside your nose. These cells extend upwards from the roof of your nose towards the smell-processing centre of your brain, called the ...

Bhad Bhabie/Instagram Bhad Bhabie revealed she got a nose job amid her cancer treatment. On Tuesday, Jan. 21, the rapper, 21, shared the news via Instagram Stories, per reposts on X. The star ...

NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression ... according to the pharmaceutical company. The nasal spray can be given to people ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Bhad Bhabie got candid about getting a nose job. Bhabie, 21, took to Instagram on Tuesday, January 21, to reveal she went under the knife. “Nose jobs are not for the weak!!” she wrote in a ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

Bhad Bhabie revealed she recently underwent surgery to get a new nose. “Day 6! Nose jobs are not for the weak!!” the “Gucci Flip Flops” rapper, 21, said while sharing several photos of her ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S ... according to the pharmaceutical company. The nasal spray can be given to people who haven’t seen improvements to their ...

reduced symptoms such as nasal congestion, sneezing, itching, and rhinorrhea (runny nose) in 90% of subjects after just two treatment cycles, with no adverse side effects. Similarly, a 2023 study ...